Immunservice
Immunservice GmbH develops biomimetic immune hormones, in particular interleukin-2, for safer, more effective and potentially curative therapies, especially in cancer.
Management
Prof. Dr. Edith Huland
Pressemeldungen
Dr. Michael Otto Invests in Innovate Immunotherapy to Prevent and Eliminate Cancer and Viral Infections
Immunservice GmbH has concluded a new round of financing (Series C) to secure development of the company’s biological immunotherapy methods for the long term. Joining the existing consortium of investors comprised of Helmut Ponath, the Hubertus-Wald-Stiftung, the High-Tech-Gründerfonds (HTGF) and Hartwig Huland…
Info & Contact
Address
Christoph-Probst-Weg 4
20251 Hamburg
20251 Hamburg
In portfolio
20. Jul 2007
